Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study-Reference-Cited by-同舟云学术

Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study

Published:2017-12-05 Issue: Volume:123 Page:5160-5177
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Steele C. Brooke¹,Li Jun¹,Huang Bin²,Weir Hannah K.¹^ORCID

Affiliation:

1. Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention; Atlanta Georgia

2. Markey Cancer Center, Kentucky Cancer Registry, and College of Public Health; University of Kentucky; Lexington Kentucky

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.31026/fullpdf

Reference62 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer;Ryerson;Cancer,2016

3. Cancer surveillance series: interpreting trends in prostate cancer-Part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates;Hankey;J Natl Cancer Inst,1999

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiomics and Artificial Intelligence in Radiotheranostics: A Review of Applications for Radioligands Targeting Somatostatin Receptors and Prostate-Specific Membrane Antigens;Diagnostics;2024-01-14

2. A qualitative study of barriers and facilitators for health behavior change in low-income men with prostate cancer;Supportive Care in Cancer;2024-01

3. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy in Clinically Significant Prostate Cancer Detection Rate? A Systematic Review and Meta-analysis;European Urology Oncology;2023-12

4. Establishment and assessment of a nomogram for predicting prognosis in bone-metastatic prostate cancer;Medicine;2023-11-03

5. Docetaxel radiosensitizes castration-resistant prostate cancer by downregulating CAV-1;International Journal of Radiation Biology;2023-10-11